Processed eucheuma seaweed
A seaweed-derived thickener and stabiliser closely related to carrageenan, used to give creamy or gel-like textures to dairy, plant-based, and processed foods.
EFSA set only a temporary acceptable daily intake because key safety data were missing. Toddlers eating brand-loyal diets may consume far more than that limit. EFSA also says it should not be used in infant formula, and there is unresolved uncertainty about gut inflammation in people with existing bowel conditions.
What is it?
Processed eucheuma seaweed (also called semi-refined carrageenan, or SRC) is extracted from red seaweed species in the Eucheuma and Kappaphycus genera by alkali treatment followed by drying and milling. Unlike fully purified carrageenan (E407), it retains more of the seaweed's insoluble cellular material. The main functional polymer is carrageenan, a large sulphated polysaccharide (complex sugar molecule).
What does it do?
The sulphated polysaccharide chains form a gel network when hydrated, binding free water and creating smooth, viscous or gel-like textures. It stabilises emulsions by preventing fat and water from separating, and suspends particles such as cocoa in chocolate milk. Because the retained cellulosic material slows full dissolution, it is often better suited than E407 to lower-cost, ambient-stable products.
Where you will see it
Chocolate milk, UHT cream, ice cream, evaporated milk, processed meat products, low-fat spreads, plant-based dairy alternatives (oat, almond and soya drinks), infant and toddler nutritional products, and some confectionery gels. On a UK label it appears as 'processed eucheuma seaweed' or 'E407a'.
What the science says
EFSA's temporary acceptable daily intake and data gaps
In its 2018 re-evaluation EFSA set a temporary group ADI of 75mg/kg body weight per day covering both E407 and E407a together. It was made temporary specifically because of missing data: no molecular weight distribution profiles for individual E407a preparations, absent stability studies under the acidic or high-temperature conditions found in many permitted food uses, and limited characterisation of the test materials used in toxicology studies. EFSA requested this information within five years, meaning the safety case remains incomplete.
EFSA established a temporary group ADI of 75mg/kg body weight per day for carrageenan and processed eucheuma seaweed combined, flagging several missing datasets including molecular weight profiles and stability data under food-relevant conditions.
High exposure in toddlers
EFSA's dietary modelling found that toddlers aged 12 to 35 months who consistently consume the same branded products (a 'brand-loyal' scenario) could reach estimated intakes of around 758mg/kg body weight per day, roughly ten times the temporary ADI. Even in average consumption scenarios toddlers were among the highest-exposed group. This does not mean harm has been demonstrated at those levels, but it does mean the safety headroom is not large for this age group.
Brand-loyal dietary modelling for toddlers produced exposure estimates of approximately 758mg/kg body weight per day, around ten times the temporary ADI set for the group.
Gut inflammation and bowel disease uncertainty
Animal and cell studies have repeatedly shown that high doses of carrageenan can trigger intestinal inflammation. EFSA acknowledged 'inadequate data on the possible relevance of carrageenan exposure for existing inflammatory bowel diseases in humans' as a significant unresolved uncertainty. A 2023 scoping review in Critical Reviews in Toxicology identified plausible biological pathways by which food-grade carrageenan and E407a could adversely affect the gut lining and microbiome. The research is at hypothesis stage for humans; a causal link has not been established.
EFSA identified inadequate human data on whether carrageenan intake is relevant to existing inflammatory bowel diseases, listing it as a significant uncertainty requiring clarification.
Animal models consistently show that high-dose carrageenan causes intestinal inflammation and altered gut barrier function; the relevance to normal dietary exposure in humans remains uncertain.
A scoping review identified hypotheses and some mechanistic evidence that E407/E407a may adversely affect the intestines via gut microbiome disruption and barrier permeability, while noting that definitive human evidence is lacking.
Carcinogenicity and genotoxicity: not a concern at food additive level
EFSA concluded that neither carrageenan nor E407a raised a concern for genotoxicity or carcinogenicity at the levels used as food additives. A critical distinction in the older literature is between food-grade carrageenan (high molecular weight, not absorbed from the gut) and 'degraded carrageenan' (poligeenan, produced by strong acid hydrolysis), which is not a food additive and is not the same substance. IARC first evaluated carrageenan in Volume 31 (1983); in Supplement 7 (1987) IARC formally classified food-grade carrageenan as Group 3 (not classifiable as to carcinogenicity in humans) and degraded carrageenan (poligeenan) as Group 2B (possibly carcinogenic to humans), based on evidence of colorectal cancer induction in rats given high doses of the degraded form. No re-evaluation has been published since.
EFSA found no concern with respect to genotoxicity or carcinogenicity for carrageenan and processed eucheuma seaweed at levels of use as food additives.
IARC classified food-grade (native) carrageenan as Group 3 (not classifiable as to carcinogenicity in humans) and degraded carrageenan (poligeenan) as Group 2B (possibly carcinogenic to humans). The group designations were formalised in Supplement 7 (1987), building on the data evaluation in Volume 31 (1983). Degraded carrageenan is not permitted as a food additive.
Not recommended in infant formula
EFSA endorsed the position that it is inadvisable to use carrageenan in infant formula from birth. This recommendation has been carried into EU legislation, which prohibits E407 and E407a in infant formula and follow-on formula. In the UK this restriction is maintained under assimilated law.
EFSA concluded that it remains inadvisable to use carrageenan (E407) or processed eucheuma seaweed (E407a) in infant formula from birth.
Where it stands with the regulators
Who should be careful
Infants: E407a is prohibited in infant formula and follow-on formula under UK and EU law, so standard formula is not a concern. Parents of toddlers who eat a lot of branded dairy or plant-based products regularly should be aware that children in this age group can reach the highest proportional intakes. People with inflammatory bowel disease (Crohn's disease, ulcerative colitis) may wish to note the unresolved scientific uncertainty about carrageenan and gut inflammation, even though a causal link in humans at food-additive levels has not been established. Look for 'processed eucheuma seaweed' or 'E407a' on the label.
The honest read
The science around E407a is genuinely unsettled in one specific area: whether it matters to people with existing bowel conditions. The carcinogenicity story is clearer, with a solid regulatory consensus that food-grade carrageenan at additive levels does not pose a cancer risk. But the gut inflammation question has not been closed. EFSA acknowledged this explicitly in 2018 and set only a temporary ADI, which is still the current position. The toddler overexposure finding is a real number from EFSA's own modelling. Animal data on gut inflammation is consistent and long-established; what remains unresolved is whether the doses that matter in rats map to real dietary intakes in people. Anyone who reads the primary literature will find a genuine, live scientific debate, not a resolved one.
Related additives
Common questions
Is E407a banned in the UK?
No. It is a permitted food additive in the UK under the assimilated EU Regulation 1333/2008 on food additives. It is prohibited specifically in infant formula and follow-on formula, but it is authorised in a wide range of other food categories.
Is E407a the same as carrageenan?
Very closely related but not identical. Both come from red seaweed and contain the same sulphated polysaccharide (carrageenan) as the functional ingredient. E407a (processed eucheuma seaweed) is less purified: it retains more of the seaweed's insoluble plant material. E407 is the more refined extract. They share a combined temporary ADI in the EFSA 2018 evaluation.
What foods contain E407a?
Chocolate milk, ice cream, UHT and pasteurised cream, processed meat products, low-fat spreads, and plant-based milk alternatives such as oat drink, almond milk and soya milk. It is particularly common in products that need to stay smooth and stable over a long shelf life.
Is E407a vegan?
Yes. It is derived entirely from red seaweed, with no animal-derived ingredients used in its production. It is widely used as a gelling and stabilising agent in vegan and plant-based products.
Sources
- EFSA Panel on Food Additives and Nutrient Sources: Re-evaluation of carrageenan (E 407) and processed Eucheuma seaweed (E 407a) as food additives (2018)
- PMC full text of the EFSA 2018 re-evaluation (open access)
- Cruickshanks et al. (2023): Evidence and hypotheses on adverse effects of carrageenan and processed eucheuma seaweed on the intestines, Critical Reviews in Toxicology
- Cohen S M and Ito N (2002): A critical review of the toxicological effects of carrageenan and processed eucheuma seaweed on the gastrointestinal tract, Critical Reviews in Toxicology 32(5):413-44
- IARC Monographs Volume 31 (1983): Carrageenan evaluation
- IARC Monographs Supplement 7 (1987): Overall evaluations of carcinogenicity -- carrageenan (Group 3) and degraded carrageenan/poligeenan (Group 2B) classifications formalised
- JECFA monograph: Carrageenan and processed eucheuma seaweed (Food Additives Series 48)
- UK FSA: Approved additives and E numbers
See this on every food you scan
NutraSafe reads the label and puts every additive into plain English, with the source, right in the app.
Get NutraSafe on the App Store